[Asia Economy Reporter Minji Lee] The KOSPI closed higher due to net buying by foreigners and individual investors.


On the 20th, the KOSPI ended the session at 2,553.50, up 0.24% (6.08 points) from the previous session. The KOSPI opened at 2,544.06, down 0.13% (3.36 points) from the previous session, fluctuated throughout the day, and closed higher.


On the 6th, dealers are working in the dealing room of Hana Bank in Euljiro, Seoul. On this day, the KOSPI index started at 2,421.79, up 8.00 points (0.33%) from the previous trading day, maintaining a strong trend. Photo by Moon Honam munonam@

On the 6th, dealers are working in the dealing room of Hana Bank in Euljiro, Seoul. On this day, the KOSPI index started at 2,421.79, up 8.00 points (0.33%) from the previous trading day, maintaining a strong trend. Photo by Moon Honam munonam@

View original image


Looking at investor trends, institutions sold stocks worth 241.9 billion KRW in the KOSPI market. Foreigners and individuals bought stocks worth 29.4 billion KRW and 202.9 billion KRW, respectively. Foreigners maintained net buying for 12 consecutive trading days including today.


In the KOSPI market, the leading stock Samsung Electronics recorded a 0.15% increase to 64,700 KRW. LG Chem (0.42%), Naver (0.18%), and Celltrion (0.85%) also showed upward trends. On the other hand, SK Hynix (-1.43%) and Samsung Biologics (-1.11%) declined.


The KOSDAQ index closed at 870.19, up 1.19% (10.24 points) on the day. The index showed a significant rise due to net buying by foreigners and institutions. Foreigners and institutions net bought stocks worth 139.7 billion KRW and 92.3 billion KRW, respectively. Individuals alone sold stocks worth 172.7 billion KRW.


In the KOSDAQ market, Celltrion Healthcare recorded 98,700 KRW, up 1.02% from the previous session. Seegene (1.15%), HL Biopharma (3.11%), Alteogen (3.45%), and Celltrion Pharm (1.79%) also rose.



Lee Kyung-min, a researcher at Daishin Securities, said, “The index reached an intraday yearly high as expectations for AstraZeneca’s early vaccine development and commercialization were reflected, but the impact was limited as the vaccine commercialization expectations had been priced in earlier. By sector, the chemical industry showed strength, and Chinese consumer stocks rose following news of Chinese Foreign Minister Wang Yi’s visit to Korea.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing